![SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS](/docs/US/2017-06-29/US20170183328A1/abs.jpg.600x600.jpg)
- 专利标题： SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS
-
申请号： US15381295申请日： 2016-12-16
-
公开(公告)号： US20170183328A1公开(公告)日： 2017-06-29
- 发明人: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
- 申请人： Pfizer Inc.
- 主分类号： C07D403/14
- IPC分类号： C07D403/14 ; C07D403/04 ; C07D401/04 ; C07D401/14
![SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS](/abs-image/US/2017/06/29/US20170183328A1/abs.jpg.150x150.jpg)
摘要：
Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
公开/授权文献
信息查询
